New York Life Investment Management »

Vir Biotechnology shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $362k 36k 10.13
2023-12-31 $150k 15k 10.06
2023-09-30 $143k 15k 9.37
2023-06-30 $435k 18k 24.53
2023-03-31 $484k 21k 23.27

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Vir Biotechnology

BlackRock
Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Geode Capital Management
Bill & Melinda Gates Foundation
Citigroup
Northern Trust
Charles Schwab Investment Management
Bank of New York Mellon
D. E. Shaw & Co
Dimensional Fund Advisors
Goldman Sachs Group
Voloridge Investment Management

View all funds holding Vir Biotechnology